Walgreens, The Leukemia & Lymphoma Society and Susan G. Komen Collaborating to Support Research in Tough-to-Treat Cancers and Increase Access to Care By LLS Staff | February 23, 2022 Read More
Highlights from ASH 2021 By Lee Greenberger, Ph.D., LLS Chief Scientific Officer | December 21, 2021 Read More
FDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia By Lee Greenberger, Ph.D. | November 11, 2021 Read More
LLS and Burlington Celebrate 20 years of Fighting Blood Cancer Together! By LLS Staff | October 18, 2021 Read More
LLS makes progress for blood cancer patients through virtual advocacy By Brianna Wilson, Senior Manager, Advocacy Communications | July 15, 2021 Read More
Highlights from ASCO 2021 By Lee Greenberger, PhD, LLS Chief Scientific Officer | June 17, 2021 The 2021 American Society of Clinical Oncology (ASCO) Annual Meeting took place last week. Read More
Because You Volunteer, Your Impact Creates a Ripple Effect By Teri Johnson, Senior Vice President, Volunteer Engagement at LLS | April 19, 2021 Read More
FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma By Lee Greenberger, PhD, Chief Scientific Officer at LLS | March 27, 2021 Read More
